Peptide Law: A Healthcare Attorney's Guide to the FD&C Act and Unapproved Drugs Holt Law The wellness world is eager for RFK Jr.'s promised move on peptides : NPR In a major policy shift, the U.S. Food and Drug Administration is reconsidering restrictions on several controversial peptides, including trending compounds like BPC 157 and Melanotan II. The move comes as demand for The FDA has issued warning letters to multiple companies marketing compounded Retatrutide, an investigational drug from Eli Lilly still in Phase II trials. While early studies have shown promising weight loss results, Retatrutide